Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in... von Rawstron, A C, Böttcher, S, Letestu, R, Villamor, N, Fazi, C, Kartsios, H, de Tute, R M, Shingles, J, Ritgen, M, Moreno, C, Lin, K, Pettitt, A R, Kneba, M, Montserrat, E, Cymbalista, F, Hallek, M, Hillmen, P, Ghia, P

Volltext

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma von de Tute, R M, Jack, A S, Child, J A, Morgan, G J, Owen, R G, Rawstron, A C

Volltext

Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders von Owen, R G, Bynoe, A G, Varghese, A, de Tute, R.M, Rawstron, A C

Volltext

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research In... von Rawstron, A C, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, R M, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, A P, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, J L, Stetler-Stevenson, M, Yuan, C, Broome, H E, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, C M, Emerson, R, Robins, H S, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, T J, Wierda, W G, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P

Volltext

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen von de Tute, Ruth M, Rawstron, Andy C, Gregory, Walter M, Child, J Anthony, Davies, Faith E, Bell, Sue E, Cook, Gordon, Szubert, Alexander J, Drayson, Mark T, Jackson, Graham H, Morgan, Gareth J, Owen, Roger G

Volltext

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders von Rawstron, Andy C, Orfao, Alberto, Beksac, Meral, Bezdickova, Ludmila, Brooimans, Rik A, Bumbea, Horia, Dalva, Klara, Fuhler, Gwenny, Gratama, Jan, Hose, Dirk, Kovarova, Lucie, Lioznov, Michael, Mateo, Gema, Morilla, Ricardo, Mylin, Anne K, Omede, Paola, Pellat-Deceunynck, Catherine, Andres, Martin Perez, Petrucci, Maria, Ruggeri, Marina, Rymkiewicz, Grzegorz, Schmitz, Alexander, Schreder, Martin, Seynaeve, Carine, Spacek, Martin, de Tute, Ruth M, Van Valckenborgh, Els, Weston-Bell, Nicky, Owen, Roger G, San Miguel, Jesus F, Sonneveld, Pieter, Johnsen, Hans E, on behalf of European Myeloma Network

Volltext

Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: res... von Yong, KL, Hinsley, S, Auner, HW, Bygrave, C, Kaiser, MF, Ramasamy, K, De Tute, RM, Sherratt, D, Flanagan, L, Garg, M, Hawkins, S, Williams, C, Cavenagh, J, Rabin, NK, Croft, J, Morgan, G, Davies, F, Owen, RG, Brown, SR

Volltext

Minimal Residual Disease in the Maintenance Setting in Myeloma: Prognostic Significance and Impact of Lenalidomide von de Tute, Ruth M, Cairns, David, Rawstron, Andy, Pawlyn, Charlotte, Davies, Faith E., Jones, John R, Kaiser, Martin F, Hockaday, Anna, Striha, Alina, Henderson, Rowena, Cook, Gordon, Russell, Nigel H., Drayson, Mark T, Jenner, Matthew W, Gregory, Walter M, Jackson, Graham, Morgan, Gareth J., Owen, Roger G.

Volltext

THU0002 Prevalence of Monoclonal B-Cell Disorders in Patients with Autoimmunity in The UK von Arumugakani, G., Thompson, J., Khukhar, F., de Tute, R.M., Tooze, R., Emery, P., McGonagle, D., Rawstron, A.C.

Volltext

THU0013 Normal CD19-Negative Plasma Cells Are Biologically Distinct from Other Normal Plasma Cells and Likely To Be Involved in Lack of Response To B-Cell Depletion for Autoimmune... von Arumugakani, G., de Tute, R.M., Newton, D.J., Morgan, G.J., Child, J.A., Owen, R., Emery, P., Jack, A.S., McGonagle, D., Tooze, R., Rawstron, A.C.

Volltext

Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diag... von Yong, K, Wilson, W, de Tute, RM, Camilleri, M, Ramasamy, K, Streetly, M, Sive, J, Bygrave, CA, Benjamin, R, Chapman, M, Chavda, SJ, Phillips, EH, del Mar Cuadrado, M, Pang, G, Jenner, R, Dadaga, T, Kamora, S, Cavenagh, J, Clifton-Hadley, L, Owen, RG, Popat, R

Volltext bestellen

Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: res... von Yong, KL, Hinsley, S, Auner, HW, Bygrave, C, Kaiser, MF, Ramasamy, K, De Tute, RM, Sherratt, D, Flanagan, L, Garg, M, Hawkins, S, Williams, C, Cavenagh, J, Rabin, NK, Croft, J, Morgan, G, Davies, F, Owen, RG, Brown, SR

Volltext bestellen

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome von Poulter, JA, Collins, JC, Cargo, C, de Tute, RM, Evans, P, Ospina Cardona, D, Bowen, DT, Cunnington, JR, Baguley, E, Quinn, M, Green, M, McGonagle, D, Beck, DB, Werner, A, Savic, S

Volltext bestellen

Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim... von Jackson, GH, Pawlyn, C, Cairns, DA, de Tute, RM, Hockaday, A, Collett, C, Jones, JR, Kishore, B, Garg, M, Williams, CD, Karunanithi, K, Lindsay, J, Rocci, A, Snowden, JA, Jenner, MW, Cook, G, Russell, NH, Drayson, MT, Gregory, WM, Kaiser, MF, Owen, RG, Davies, FE, Morgan, GJ, the UK NCRI Haemato-oncology Clinical Studies Group

Volltext bestellen

Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at r... von Cohen, OC, Counsell, N, Rabin, N, Popat, R, Owen, RG, Popova, B, Schofield, O, Clifton-Hadley, L, Lyons-Lewis, J, Rawstron, A, Spence, C, de Tute, RM, Hughes, D, Moore, S, Smith, P, Yong, KL

Volltext bestellen

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome von Poulter, James A., Collins, Jason C., Cargo, Catherine, De Tute, Ruth M., Evans, Paul, Ospina Cardona, Daniela, Bowen, David T., Cunnington, Joanna R., Baguley, Elaine, Quinn, Mark, Green, Michael, McGonagle, Dennis, Beck, David B., Werner, Achim, Savic, Sinisa

Volltext

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes von van Dongen, J J M, Lhermitte, L, Böttcher, S, Almeida, J, van der Velden, V H J, Flores-Montero, J, Rawstron, A, Asnafi, V, Lécrevisse, Q, Lucio, P, Mejstrikova, E, Szczepański, T, Kalina, T, de Tute, R, Brüggemann, M, Sedek, L, Cullen, M, Langerak, A W, Mendonça, A, Macintyre, E, Martin-Ayuso, M, Hrusak, O, Vidriales, M B, Orfao, A

Volltext

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols von Kalina, T, Flores-Montero, J, van der Velden, V H J, Martin-Ayuso, M, Böttcher, S, Ritgen, M, Almeida, J, Lhermitte, L, Asnafi, V, Mendonça, A, de Tute, R, Cullen, M, Sedek, L, Vidriales, M B, Pérez, J J, te Marvelde, J G, Mejstrikova, E, Hrusak, O, Szczepański, T, van Dongen, J J M, Orfao, A

Volltext

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk von de Tute, Ruth M, Pawlyn, Charlotte, Cairns, David A, Davies, Faith E, Menzies, Tom, Rawstron, Andy, Jones, John R, Hockaday, Anna, Henderson, Rowena, Cook, Gordon, Drayson, Mark T, Jenner, Matthew W, Kaiser, Martin F, Gregory, Walter M, Morgan, Gareth J, Jackson, Graham H, Owen, Roger G

Volltext

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma von Kaiser, Martin F, Hall, Andrew, Walker, Katrina, Sherborne, Amy, De Tute, Ruth M, Newnham, Nicola, Roberts, Sadie, Ingleson, Emma, Bowles, Kristian, Garg, Mamta, Lokare, Anand, Messiou, Christina, Houlston, Richard S, Jackson, Graham, Cook, Gordon, Pratt, Guy, Owen, Roger G, Drayson, Mark T, Brown, Sarah R, Jenner, Matthew W

Volltext